A letter announcing provincial listing for a drug is required to undergo preclearance if includes reimbursement criteria/indication. Note that the preclearance exemption under PAAB code section 6.6(d).ii. only applies to a formulary listing announcement which is not linked to a therapeutic claim in any way (e.g. an ad containing only the product name and "Now on formulary").
